wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33899954-EF7C39E8-CB78-4948-ACB7-B8B5DD21E4A6
Q33899954-EF7C39E8-CB78-4948-ACB7-B8B5DD21E4A6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33899954-EF7C39E8-CB78-4948-ACB7-B8B5DD21E4A6
Pancreatic cancer: molecular pathogenesis and new therapeutic targets.
P2860
Q33899954-EF7C39E8-CB78-4948-ACB7-B8B5DD21E4A6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33899954-EF7C39E8-CB78-4948-ACB7-B8B5DD21E4A6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
26ff8f9421e70b400ef5e20d7446ebb353055c47
P2860
A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancer.